Faculty Disclosures
| Eoin P. Flanagan, MBBCh, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Stacey Clardy, MD, PhD, FÂ鶹´«Ã½Ó³» |
Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/Â鶹´«Ã½Ó³» Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³» Summer Meeting CoDirector Travel and Lodging with Â鶹´«Ã½Ó³». Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed. |
| Sean J. Pittock, MD, FÂ鶹´«Ã½Ó³» |
Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Jeffrey L. Bennett, MD, PhD, FÂ鶹´«Ã½Ó³» |
Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care. |
| James F. Howard, Jr., MD, FÂ鶹´«Ã½Ó³» |
Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Jenny Linnoila, MD, PhD |
Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/Vaccine Injury Compensation Program. Dr. Linnoila has a non-compensated relationship as a member of the Medical Advisory Board, Research Subcommittee, with Autoimmune Encephalitis Alliance that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Shamik Bhattacharyya, MD, FÂ鶹´«Ã½Ó³» |
Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. The institution of Dr. Bhattacharyya has received research support from TG Therapeutics. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. |
| Melissa A. Wright, MD |
Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . |
| Jeffrey M. Gelfand, MD, MS, FÂ鶹´«Ã½Ó³» |
Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Bruce A. Cree, MD, PhD, MAS, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care. |
| Thais Armangue, MD |
Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP. |
| Kiran Thakur, MD, FÂ鶹´«Ã½Ó³» |
Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. |
| Michael Levy, MD, PhD, FÂ鶹´«Ã½Ó³» |
Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health. |
| Amanda L. Piquet, MD, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Jamie C. McDonald, MD |
Dr. McDonald has nothing to disclose. |
| Spencer Hutto, MD |
Dr. Hutto has nothing to disclose. |
| Adrian Budhram, MD |
Dr. Budhram has nothing to disclose. |
| Alessandro Dinoto, MD |
The institution of Dr. Dinoto has received research support from Encephalitis International . The institution of Dr. Dinoto has received research support from Autoimmune Encephalitis Alliance. |
| Tammy L. Smith, MD, PhD |
Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca. |
| Sara Mariotto, MD, PhD |
Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, Â鶹´«Ã½Ó³». The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM. |
| Jacqueline Palace |
Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care. |
| Romain Marignier, MD, PhD |
Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. |
| Amy M. Quek, MBBS |
The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. |
| Marcelo Matiello, MD, FÂ鶹´«Ã½Ó³» |
Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer. |
| Philippe-Antoine Bilodeau, MD |
The institution of Dr. Bilodeau has received research support from Alexion Pharmaceuticals. The institution of Dr. Bilodeau has received research support from Department of Defense. Dr. Bilodeau has received research support from Canadian Institutes of Health Research. The institution of Dr. Bilodeau has received research support from Ann Theodore Foundation. Dr. Bilodeau has received research support from The MOG Project. |
| Sydney Lee, MD |
Dr. Lee has nothing to disclose. |
| Kristin M. Galetta, MD |
Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS. |
| Sara Moss, MD |
Dr. Moss has nothing to disclose. |
| Amara Plaza-Jennings, MD, PhD |
Amara Plaza-Jennings has nothing to disclose. |
| Samantha Hao, MD |
Ms. Hao has nothing to disclose. |
| Michel T. Torbey, MD, MPH, FÂ鶹´«Ã½Ó³» |
Dr. Torbey has nothing to disclose. |
| Emma Ciafaloni, MD, FÂ鶹´«Ã½Ó³» |
Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care. |
| Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³» |
Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE. |
| Kimiaki Utsugisawa, MD, PhD |
Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. |
| Aksel Siva, MD |
Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants. |
| Kazuo Fujihara, MD |
Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin. |
| Ayse Altintas, MD |
Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
| Benjamin Ong, MBBS |
Prof. Ong has nothing to disclose. |
| Orhan Aktas, MD |
Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS). |
| Jesus Lovera, MD |
Dr. Lovera has nothing to disclose. |
| Michael G. Benatar, MBChB, DPhil, FÂ鶹´«Ã½Ó³» |
Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care. |
| John Vissing, MD |
Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi. |
| Friedemann Paul |
Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation. |
| Richard J. Nowak, MD |
Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Jodie Burton, MD, FÂ鶹´«Ã½Ó³» |
Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Burton has a non-compensated relationship as a Â鶹´«Ã½Ó³»al Chair with EMD Serono that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Ho Jin Kim, MD |
Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology. |
| Carolin Dohle, MD |
Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. |
| Ali A. Habib, MD |
Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals. |
| Tania Kuempfel, MD |
Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. |
| Jin Li, MD, PhD, FÂ鶹´«Ã½Ó³» |
Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with Â鶹´«Ã½Ó³» that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Michael W. Nicolle, MD |
Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Argenx, Amgen, UCB, Kye, J&J. Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicolle has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various legal firms. |
| Alessandro Serra, MD |
Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. |
| Yakov Isakov, DO |
Dr. Isakov has nothing to disclose. |
| Jeffrey E. Dunn, MD, FÂ鶹´«Ã½Ó³» |
Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics. Dr. Dunn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna Therapeutics. Dr. Dunn has received intellectual property interests from a discovery or technology relating to health care. |
| Rima N. El-Abassi, MD |
Dr. El-Abassi has nothing to disclose. |
| Katrin Gross-Paju, MD, PhD |
Dr. Gross-Paju has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Gross-Paju has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gross-Paju has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. |
| Maciej Jurynczyk, MD |
Dr. Jurynczyk has nothing to disclose. |
| Maria I. Leite, MD |
The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK. |
| Christopher A. Scheiner, MD, PhD |
Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals . |
| Diana Vargas, MD |
Dr. Vargas has nothing to disclose. |
| Paulus S. Rommer |
Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen. |
| Wei Ping Kay Ng, MD |
Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. |
| Jelena Drulovic |
Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PharmaSwiss. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actavis TEVA. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medis. Jelena Drulovic has received research support from Ministry of Science, Technological Development and Innovations of the Republic of Serbia. |
| Irena Dujmovic Basuroski, MD, PhD |
The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation. |
| Adam De Havenon, MD, FÂ鶹´«Ã½Ó³» |
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Saher Choudhary, MD |
Dr. Choudhary has nothing to disclose. |
| Tania Reyna, MD, FÂ鶹´«Ã½Ó³» |
Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . |
| Barbara Willekens, MD, PhD, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall . The institution of Dr. Willekens has received research support from Roche. The institution of Dr. Willekens has received research support from Janssen. Dr. Willekens has a non-compensated relationship as a Co-chair scientific panel of neuroimmunology with European Academy of Neurology that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Beth Stein, MD |
Dr. Stein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Stein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Stein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Stein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson . Dr. Stein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Stein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Stein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Stein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson & Johnson. |
| Tuan H. Vu, MD |
Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VOR. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR. The institution of Dr. Vu has received research support from NMD Pharma. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with AcademicCME. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with CMEO. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with PER. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with MedLive. |
| David R. Benavides, MD, PhD, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd. |
| Vikram Prakash, MD |
Dr. Prakash has nothing to disclose. |
| Cesar Caparo, MD |
Dr. Caparo has nothing to disclose. |
| Rajesh K. Gupta, MBBS |
Dr. Gupta has nothing to disclose. |
| Raymond C. Seet, MD |
Dr. Seet has nothing to disclose. |
| Ning S. Yang, MD |
Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Yang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. |
| Scott M. Belliston, DO |
Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Shitiz K. Sriwastava, MBBS |
Dr. Sriwastava has nothing to disclose. |
| Maria Ernestina Moreira Santos, MD |
Maria Ernestina Moreira Santos, MD has nothing to disclose. |
| Lily Pham, MD |
Dr. Pham has nothing to disclose. |
| Derek T. Soon, MBBS, PhD |
Dr. Soon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legal Clinic. |
| Guido Sabatella |
Guido Sabatella has received personal compensation for serving as an employee of Alexion. |
| Monica M. Diaz, MD, MS |
The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund. |
| Syed A. Shah, MD |
Dr. Shah has nothing to disclose. |
| Nidhiben A. Anadani, MD |
Dr. Anadani has nothing to disclose. |
| Edison Vasquez, MD |
Dr. VASQUEZ has nothing to disclose. |
| Ka-Ho Wong |
The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association. |
| Shahd H. Hamid, MBBS |
Dr. Hamid has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Merck Novartis . |
| Lesley Kaye, MD |
The institution of Dr. Kaye has received research support from NeuroPace. The institution of Dr. Kaye has received research support from LivaNova. |
| Rajiv Anand, MD |
Dr. Anand has nothing to disclose. |
| Nicholas Lannen, MD |
Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics. |
| Danny Samkutty, MD |
Dr. Samkutty has nothing to disclose. |
| Ashley E. Aaroe, MD |
Dr. Aaroe has received personal compensation in the range of $10,000-$49,999 for serving as a Delphi Panel Consultant with Advi. |
| Natasha Hameed, MD |
Dr. Hameed has nothing to disclose. |
| Sonia M. Caraballo-Cartagena, MD |
Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. |
| Andrew Chan |
The institution of Andrew Chan has received research support from UCB. The institution of Andrew Chan has received research support from Biogen. The institution of Andrew Chan has received research support from Sanofi Genzyme. |
| Suzanne Liu, MD |
The institution of an immediate family member of Dr. Liu has received research support from NIH. |
| Daniel P. Kurz, MD |
An immediate family member of Dr. Kurz has received personal compensation for serving as an employee of Grainger. Dr. Kurz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation for Sarcoidosis Research. An immediate family member of Dr. Kurz has or had stock in Grainger. The institution of Dr. Kurz has received research support from Biogen. |
| Omar Akhand, MD |
Dr. Akhand has nothing to disclose. |
| Michael V. Robers, MD |
Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. |
| Sara Radmard, MD |
Dr. Radmard has nothing to disclose. |
| Lisa K. Peterson, PhD |
Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Peterson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Werfen. Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AliveDx. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Biochemistry. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lab Q for ASCP. Dr. Peterson has a non-compensated relationship as a President with Association of Medical Laboratory Immunologists that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Nikita Shukla, MD |
The institution of Dr. Shukla has received research support from Roche. |
| Michael L. Palm, MD, FÂ鶹´«Ã½Ó³» |
Dr. Palm has received personal compensation in the range of $0-$499 for serving as a Member of the UCNS Accreditation Council with United Council for Neurologic Subspecialties. |
| Kerstin Allen |
Kerstin Allen has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Kerstin Allen has stock in Alexion, AstraZeneca Rare Diseas. |
| Kristen Fisher, DO |
Dr. Fisher has nothing to disclose. |
| Svetlana Faktorovich, MD, FÂ鶹´«Ã½Ó³» |
Dr. Faktorovich has a non-compensated relationship as a member of the Board of Trustees with Brother's Brother Foundation that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Kyna Schreiber, MD |
Dr. Schreiber has received research support from NIH. |
| Daniel Calame, MD, PhD |
Dr. Calame has nothing to disclose. |
| Torge Rempe, MD |
Dr. Rempe has nothing to disclose. |
| Kathryn Holroyd, MD |
The institution of Dr. Holroyd has received research support from NINDS. |
| Gabriela A. Bou, MD |
Dr. Bou has nothing to disclose. |
| Rucha Bahekar, MBBS |
Dr. Bahekar has nothing to disclose. |
| Heather Yong, MD |
Dr. Yong has nothing to disclose. |
| Maria A. Garcia-Dominguez, MD |
Dr. Garcia-Dominguez has received personal compensation for serving as an employee of Genentech. |
| Anastasia Vishnevetsky, MD |
The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext). |
| Erik A. Guevara-Silva, MD |
Dr. Guevara-Silva has nothing to disclose. |
| Xiaowei W. Su, MD, PhD |
The institution of Dr. Su has received research support from H. G. Barsumian, M.D. Memorial Fund. |
| Sarah E. Fredrich, MD |
Dr. Fredrich has nothing to disclose. |
| Rani Priyanka Vasireddy, MBBS |
Dr. Vasireddy has nothing to disclose. |
| Alexander Sandweiss, MD, PhD |
Dr. Sandweiss has nothing to disclose. |
| Ahmed Abbas, MD |
Dr. Abbas has nothing to disclose. |
| Georgina Arrambide, MD, PhD |
The institution of Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Arrambide has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Platform Adaptive Trial for remyelination and neuroprotection in mUltiple Sclerosis (PLATYPUS) . The institution of Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Arrambide has received research support from Instituto de Salud Carlos III. Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving as a Travel support for scientific meetings with Novartis. Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving as a Travel support for scientific meetings with Roche. Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving as a Travel support for scientific meetings with ECTRIMS. Dr. Arrambide has received personal compensation in the range of $500-$4,999 for serving as a Travel support for scientific meetings with EAN. Dr. Arrambide has a non-compensated relationship as a Member of the Executive Committee with iWiMS that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Arrambide has a non-compensated relationship as a Member of the steering committee with BioMS-eu that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Arrambide has a non-compensated relationship as a Member of the steering group with MOGAD Eugene Devic European Network (MEDEN) that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Arrambide has a non-compensated relationship as a Member of the editorial and scientific committee with Acta Neurológica Colombiana that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Arrambide has a non-compensated relationship as a Member of the steering committee with CURE-MS that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Shahar Shelly, MD |
Dr. Shelly has or had stock in Remepy. |
| Gina S. Perez-Giraldo, MD |
Dr. Perez-Giraldo has received personal compensation for serving as an employee of TG therapeutics. Dr. Perez-Giraldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics. |
| Stefanie J. Rodenbeck, MD |
Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving as a interview appearance with TG Therapeutics. |
| Daniel Lax, MD |
Dr. Lax has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Lax has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with American Headache Society. |
| Yihui Goh, MBBS |
Dr. Goh has nothing to disclose. |
| Ahya S. Ali, MD |
Dr. Ali has nothing to disclose. |
| Rui T. Tang, MD |
Dr. Tang has nothing to disclose. |
| Eric p. Yeager, MD |
Mr. Yeager has nothing to disclose. |
| Aatqa Memon, MD |
Dr. Memon has nothing to disclose. |
| Ava M. Easton, PhD |
Dr. Easton has received personal compensation for serving as an employee of Encephalitis Society. Dr. Easton has received publishing royalties from a publication relating to health care. |
| Chukwuma E. Nwaze, MBBS |
Dr. Nwaze has nothing to disclose. |
| Yoji Hoshina, MD |
Dr. Hoshina has nothing to disclose. |
| Rebecca Salky |
Rebecca Salky has nothing to disclose. |
| Cecilia Rajda, MD, PhD |
Dr. Rajda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rajda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. |
| Anna J. Tomczak, MSc |
Miss Tomczak has nothing to disclose. |
| Rasha Aguzzi |
Rasha Aguzzi has received personal compensation for serving as an employee of Alexion Pharmaceutical. Rasha Aguzzi has or had stock in AstraZeneca. |
| Ario Mirian, MD |
Dr. Mirian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Mirian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. |
| Yiu-Chia Chang, MD |
Dr. Chang has nothing to disclose. |
| Vicky Chen, MD |
Dr. Chen has received research support from OHSU Foundation. |
| Ronak K. Kapadia, MD |
Dr. Kapadia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics/Amgen. |
| Lucas Horta, MD |
Dr. Horta has nothing to disclose. |
| Abeer Safan, MD |
Dr. Safan has nothing to disclose. |
| Michele Persico, MD |
Dr. Persico has nothing to disclose. |
| Karla Salazar, MD |
Dr. Salazar has nothing to disclose. |
| Mahmoud Elkhooly, MD |
Dr. Elkhooly has nothing to disclose. |
| Subhan Khan, MD |
Dr. Khan has received personal compensation for serving as an employee of University of Kentucky. |
| Catherine Najem, PhD |
Dr. Najem has received personal compensation for serving as an employee of Janssen R&D US. |
| Andrea Zhang, MD |
Dr. Zhang has nothing to disclose. |
| Anthony Shock |
Anthony Shock has received personal compensation for serving as an employee of UCB Pharma. |
| Sarah E. Lam, MD |
Dr. Lam has nothing to disclose. |
| Shirali Pandya, PhD |
Dr. Pandya has received personal compensation for serving as an employee of Alexion, Astra Zeneca Rare Disease. Dr. Pandya has received personal compensation for serving as an employee of Rhythm Pharmaceuticals. Dr. Pandya has stock in Sanofi. Dr. Pandya has stock in Alexion, Astra Zeneca Rare Disease. |
| Jonathan Trout, MD |
Dr. Trout has nothing to disclose. |
| Christoper A. Alarcon Ruiz, MD |
Dr. Alarcon Ruiz has received research support from Universidad Científica del Sur. |
| Daniel E. Kaufman |
Mr. Kaufman has nothing to disclose. |
| Michael Blackowicz, PhD |
Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals. |
| Mamadou Diallo, MD |
Dr. Diallo has nothing to disclose. |
| Fang Yu, MD |
Dr. Yu has nothing to disclose. |
| Sangharsha Thapa, MD |
Dr. Thapa has nothing to disclose. |
| Lulu Bursztyn |
Lulu Bursztyn has nothing to disclose. |
| Ruba D. Bou-Chahine |
Dr. Bou-Chahine has nothing to disclose. |
| Mario Habek |
Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. An immediate family member of Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Mario Habek has received research support from Croatian Science Foundation. |
| Giuseppe Lauria |
Giuseppe Lauria has nothing to disclose. |
| Kumaran Deiva |
Kumaran Deiva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Kumaran Deiva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kumaran Deiva has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Kumaran Deiva has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kumaran Deiva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octagam. Kumaran Deiva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sqy therapeutics. |
| Liam Townley, MD |
Dr. Townley has nothing to disclose. |
| Zachary Roccaforte, MD |
Dr. Roccaforte has nothing to disclose. |
| Emma Weiskopf, MD |
Dr. Weiskopf has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Weiskopf has or had stock in Alexion Astrazeneca Rare Disease. |
| Juber D. Shaikh, MD, DM (neurology) |
Dr. Shaikh has nothing to disclose. |
| Abhinbhen W. Saraya, MD |
Dr. Saraya has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biofire. |
| Alaa S. Mohamed, MD, MBBS |
Dr. Mohamed has nothing to disclose. |
| Danielle Pitter, MD |
Dr. Pitter has nothing to disclose. |
| Deepinder K. Maini, PhD |
Dr. Maini has nothing to disclose. |
| Gerome B. Vallejos, MD |
Dr. Vallejos has nothing to disclose. |
| Nirbha Ghurye, MBBS |
Dr. Ghurye has nothing to disclose. |
| Krishna Kanth Ravi, MD, MBBS, DNB DM |
Dr. Ravi has nothing to disclose. |
| Jon Rosenberg, MD |
Dr. Rosenberg has nothing to disclose. |
| David Sandlin, MD, PhD |
Dr. Sandlin has nothing to disclose. |
| Tamara Sleem, MD |
Ms. Sleem has nothing to disclose. |
| Benjamin Yungher, PhD |
Dr. Yungher has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. |
| Aiswarya Raj, MBBS |
Dr. Raj has nothing to disclose. |
| Jessica V. Amos, MD |
Mrs. Amos has nothing to disclose. |
| Michael I. Nsaka, MD, PhD |
Dr. Nsaka has nothing to disclose. |
| Mhd Majd Mardini, MD |
Dr. Mardini has nothing to disclose. |
| Steven Everett |
Mr. Everett has nothing to disclose. |
| Ipshita Garg, MBBS |
Dr. Garg has nothing to disclose. |
| Abdallah Abunamoos |
Dr. Abunamoos has nothing to disclose. |
| Tim Friede, PhD |
Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RECARDIO. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Daiichi Sankyo. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Prof. Friede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BiosenseWebster. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Enanta. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VICO Therapeutics. Prof. Friede has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Fresenius Kabi Deutschland GmbH. |
| Mai Sato, PhD |
Dr. Sato has received personal compensation for serving as an employee of ZS Associates. |
| Anjeli Inscore, PsyD |
Dr. Inscore has nothing to disclose. |
| Tirath Patel |
Mr. Patel has nothing to disclose. |
| VARUN REHANI |
Dr. REHANI has nothing to disclose. |
| Sue Cheng |
Sue Cheng has received personal compensation for serving as an employee of Amgen. |
| Khaled Zammar, MD, MSc |
Dr. Zammar has nothing to disclose. |
| Michael Devlin |
Mr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for The Sumaira Foundation. |
| Nithyashri Baskaran |
Ms. Baskaran has nothing to disclose. |
| Katie Detmer, MD |
Dr. Detmer has nothing to disclose. |
| Taqua Tabassum, MD |
Dr. Tabassum has nothing to disclose. |
| Jesus Daniel Gutierrez Arratia, MD |
Dr. Gutierrez Arratia has nothing to disclose. |
| Vera Nemsadze, MD |
Dr. Nemsadze has nothing to disclose. |
| Jerilyn Summay, MD |
Dr. Summay has nothing to disclose. |
| Usama Khan, MD |
Dr. Khan has nothing to disclose. |
| Ereny Mikhael, MD |
Dr. Mikhael has nothing to disclose. |
| Aliu O. Yakubu, MBBS |
Dr. Yakubu has nothing to disclose. |
| Sai Pratibha Yandamuri |
Miss Yandamuri has nothing to disclose. |
| Majd A. AbuAlrob, MD |
Dr. AbuAlrob has nothing to disclose. |
| Michael J. McGill, MD |
Dr. McGill has nothing to disclose. |
| Kelli Manikowski, DO |
Mrs. Manikowski has nothing to disclose. |
| Beatriz Garcia Cañibano, MD |
Dr. Garcia Cañibano has nothing to disclose. |
| Kassem Al Asaad, MBBS |
Kassem Al Asaad, MBBS has nothing to disclose. |
| Lauren Bell, MD |
Dr. Bell has nothing to disclose. |
| Hafiz Talha Javed, MD |
Dr. Javed has nothing to disclose. |
| Rebecca Allen, MD |
Dr. Allen has nothing to disclose. |
| Bara M. Hammadeh |
Mr. Hammadeh has nothing to disclose. |
| Dan Case |
Mr. Case has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Mr. Case has stock in AstraZeneca. |
| Swapna Karkare |
Swapna Karkare has received personal compensation for serving as an employee of argenx. Swapna Karkare has stock in argenx. |
| Ali Karimi |
Mr. Karimi has nothing to disclose. |
| Gregory Atafo, MBChB |
Dr. Atafo has nothing to disclose. |
| Michaele Garrison, DO |
Dr. Garrison has nothing to disclose. |
| MOHAMMAD ALKHALDI, MD |
Dr. ALKHALDI has nothing to disclose. |
| Anusha Sanivarapu, MD |
Anusha Sanivarapu has nothing to disclose. |
| Tracey Nicole Webb, MD |
Dr. Webb has nothing to disclose. |
| Farah Barakat, MD, MBBS |
Ms. Barakat has nothing to disclose. |
| Nadia Zaveri |
Ms. Zaveri has or had stock in Argenx .Ms. Zaveri has received personal compensation in the range of $100,000-$499,999 for serving as a Senior Director, Medical Affairs with argenx. |
| Filemon C. Tan III, BS |
Mr. Tan has nothing to disclose. |
| NagaVenkata Priya Sri Harshitha Somarouthu |
Miss Somarouthu has nothing to disclose. |
| Sai Sahithi Reddy m. Atla |
Miss Atla has nothing to disclose. |
| Aprajita Bhorkar |
Aprajita Bhorkar has nothing to disclose. |
| Muhammad Sarim S. Azad Khan, MBBS |
Mr. Azad Khan has nothing to disclose. |
| Veronica M. Andrade |
Ms. Andrade has nothing to disclose. |
| Divya Ramamoorthy, PhD |
Dr. Ramamoorthy has nothing to disclose. |
| Daniel F. Guijo, MD |
Daniel F. Guijo, MD has nothing to disclose. |
| Dev Gavande, High School Student |
Mr. Gavande has nothing to disclose. |
| Sanjeet Kumar, Jr., MBBS |
Mr. Kumar has nothing to disclose. |
| Olorungbami K. Anifalaje, MBBS |
Dr. Anifalaje has nothing to disclose. |
| Chioma M. Muotoh, MBBS |
Dr. Muotoh has nothing to disclose. |
| Moses G. Effiong |
Dr. Effiong has nothing to disclose. |
| Nicole J. Al Alam Rabie |
Nicole J. Al Alam Rabie has nothing to disclose. |
| Wanling Zou, PhD |
Dr. Zou has received personal compensation for serving as an employee of ZS Associates. |
| Favour C. Ezem, MBBS |
Dr. Ezem has nothing to disclose. |
| Laya Krishnan, BS |
Ms. Krishnan has nothing to disclose. |
| Jason Zucker, MD |
Dr. Zucker has nothing to disclose. |
| Shankar Biswas, MD |
Dr. Biswas has nothing to disclose. |
| Marc El Khoury, MD |
Dr. El Khoury has received personal compensation in the range of $500-$4,999 for serving as a Peer reviewer for the VA with IPRO. |
| Sonali Ajwani |
Miss Ajwani has nothing to disclose. |
| Sindhu Vasireddy, MD |
Dr. Vasireddy has nothing to disclose. |
| Sarah Bray, PhD |
Dr. Bray has received personal compensation for serving as an employee of Amgen Ltd. Dr. Bray has stock in Amgen Ltd. |
| Irem Celen, PhD |
Dr. Celen has nothing to disclose. |
| Yashasvi Srivastava, MBBS |
Ms. Srivastava has nothing to disclose. |
| Alexandra Diaz-Ariza |
Ms. Diaz-Ariza has nothing to disclose. |
| Marianna Lalla, MD, PhD |
Dr. Lalla has nothing to disclose. |
| YANG ZHAO, PhD |
Dr. ZHAO has received personal compensation for serving as an employee of Dianthus Therapeutics. Dr. ZHAO has received personal compensation for serving as an employee of Viridian Therapeutics. Dr. ZHAO has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roivant. Dr. ZHAO has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MindImmune Therapeutics. Dr. ZHAO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slater Tech Fund. |
| Linda Rehaume, PhD |
Dr. Rehaume has received personal compensation for serving as an employee of Dianthus Therapeutics, Inc. Dr. Rehaume has received personal compensation for serving as an employee of Aurinia Pharmaceuticals Inc. Dr. Rehaume has stock in Aurinia Pharmaceuticals Inc. |
| Jennifer Cross, PhD |
Dr. Cross has received personal compensation for serving as an employee of Dianthus Therapeutics. Dr. Cross has stock in Dianthus Therapeutics. |
| Lorenzo Maggi |
Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Lorenzo Maggi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Lorenzo Maggi has received research support from Ministry of Health. |
| Yayoi Kumata, DO |
Dr. Kumata has nothing to disclose. |
| Simian Huang |
Miss Huang has nothing to disclose. |
| Kristina Patterson |
No disclosure on file
|
| Subhasree Misra, MD |
Dr. Misra has nothing to disclose. |
| Rebecca Novak |
Rebecca Novak has received personal compensation for serving as an employee of Veeva Systems Inc. |
| Parissa A. Feizi, MD |
No disclosure on file
|
| Haroon Z. Ahmad, MD |
Dr. Ahmad has nothing to disclose. |
| Neil K. Sharma, MD |
Dr. Sharma has nothing to disclose. |
| Thomas Wallace, PhD |
Dr. Wallace has received personal compensation for serving as an employee of UCB. Dr. Wallace has or had stock in UCB. |
| Susmitha Yella, MD |
Dr. Yella has nothing to disclose. |
| Logan Harper |
No disclosure on file
|
| Austin J. DeTavis, DO |
Dr. DeTavis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superior Biodiagnostics. |
| Bilge Nur Yesiltepe, MD |
Dr. Yesiltepe has or had stock in AYTU Biopharma INC.Dr. Yesiltepe has or had stock in Inovio Pharmaceuticals Inc. |
| Ashlynn-Joy P. Fajayan, DO |
Dr. Fajayan has nothing to disclose. |
| Manoj R. Pallapothu, MD |
Dr. Pallapothu has nothing to disclose. |
| Jonah Kuvin, DO |
Dr. Kuvin has nothing to disclose. |
| Adaadinchezo Oguejiofor, MD |
Dr. Oguejiofor has nothing to disclose. |
| Sarah W. Khan, MD |
Dr. Khan has nothing to disclose. |
| Sara M. Ahmed, MD |
Dr. Ahmed has nothing to disclose. |
| Mohamad M. Assker, MBBS |
Mr. Assker has nothing to disclose. |
| Mohammad Hani, MBBS |
Dr. Hani has nothing to disclose. |
| Dustin Ryker, MD |
Dr. Ryker has nothing to disclose. |
| Jacob S. Tremoulis, DO |
No disclosure on file
|
| Asma T. Khan, MD |
Dr. Khan has nothing to disclose. |
| Oranuch Chuapakdee, MD |
Miss Chuapakdee has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for VIATRIS. |
| Yanira B. Nuñez Ramirez |
Dr. Nuñez Ramirez has nothing to disclose. |
| Sana Rashid, Jr., MBBS |
Dr. Rashid has nothing to disclose. |
| Ritesh R. Baddam, MD |
Dr. Baddam has nothing to disclose. |
| Emily Bruder, MD |
Dr. Bruder has nothing to disclose. |
| Elif Dogan, MD |
Dr. Dogan has nothing to disclose. |
| Hasnain W. Saqib, MBBS |
Dr. Saqib has nothing to disclose. |
| Meggan Macias, PA |
Mrs. Macias has nothing to disclose. |
| Wajid Jawaid, FCPS Neurology, FEBN |
Dr. Jawaid has nothing to disclose. |
| BHAVYA Y. DESAI, MBBS |
Dr. DESAI has nothing to disclose. |
| Athira Nair, MD |
Dr. Nair has nothing to disclose. |
| Elisabeth Kamano, MD |
Dr. Kamano has nothing to disclose. |
| María E. Escoto |
Miss Escoto has nothing to disclose. |
| Anish Natarajan |
Mr. Natarajan has nothing to disclose. |
| Chiara Scopice |
Ms. Scopice has nothing to disclose. |
| Katherine Sclafani |
Miss Sclafani has nothing to disclose. |
| Kasyap Kondury |
Kasyap Kondury has nothing to disclose. |
| Kleber O. Mosquera, Sr., MD |
Dr. Mosquera has nothing to disclose. |
| Syed Tasbeel Mehdi, MBBS |
Mr. Mehdi has nothing to disclose. |
| Fnu Urooba |
Dr. Urooba has nothing to disclose. |
| Meva Ram, MBBS |
Mr. Ram has nothing to disclose. |
| Michaela Schlader-Ratzinger, MD |
Dr. Schlader-Ratzinger has received personal compensation for serving as an employee of Amgen GmbH. Dr. Schlader-Ratzinger has stock in Amgen Inc.. |
| Kelvin H. Alvarez Toledo, MBBS |
Dr. Alvarez Toledo has nothing to disclose. |
| Hannah Stokan, BS |
Ms. Stokan has nothing to disclose. |
| Mayte I. Quevedo, Bach en Psicología |
Mrs. Quevedo has nothing to disclose. |
| Brandon M. Nguyen |
Mr. Nguyen has nothing to disclose. |
| Maria Meza-Vega |
Dr. Meza-Vega has nothing to disclose. |
| Leyla R. Herbst |
Ms. Herbst has nothing to disclose. |
| Karla Pérez |
Miss Pérez has nothing to disclose. |
| Phuong Phan, PharmD |
Ms. Phan has received personal compensation for serving as an employee of AstraZeneca. Ms. Phan has or had stock in AstraZeneca. |
| Kendall Gassman, Medical Student |
Ms. Gassman has nothing to disclose. |
| Joslynn Soria |
Ms. Soria has nothing to disclose. |
| Vindhya S. Chavali, MD, MBBS |
Ms. Chavali has nothing to disclose. |
| Kadambari H. Vyas |
Miss Vyas has nothing to disclose. |
| Akaluck Thatayatikom, MD |
Dr. Thatayatikom has nothing to disclose. |
| Vincent Tran, Medical Student |
Mr. Tran has nothing to disclose. |
| Ragalikhith Kesamneni, Sr., MD |
Dr. Kesamneni has nothing to disclose. |
| Farkhanda Maqbool, MBBS |
Dr. Maqbool has nothing to disclose. |
| Isabell M. Landestoy, MD |
Dr. Landestoy has nothing to disclose. |
| Jonathan Manoukian |
Mr. Manoukian has received personal compensation for serving as an employee of argenx. |
| Carmine Colavecchia, PhD, PharmD |
Ms. Colavecchia has received personal compensation for serving as an employee of Pfizer. Ms. Colavecchia has received personal compensation for serving as an employee of argenx. Ms. Colavecchia has or had stock in Pfizer.Ms. Colavecchia has or had stock in argenx. |
| Laiba Iqbal |
Miss Iqbal has nothing to disclose. |
| Elisabeth A. Hildenbrandt |
Miss Hildenbrandt has nothing to disclose. |
| Mark Hoffman |
Mr. Hoffman has nothing to disclose. |
| Ayesha Hassan, MBBS |
Miss Hassan has nothing to disclose. |
| Mehwish Shoaib |
Miss Shoaib has nothing to disclose. |
| Caleb Karani, MBBS |
Mr. Karani has nothing to disclose. |
| Tahreem Sajjad, MBBS |
Dr. Sajjad has nothing to disclose. |
| Farheen Kooliyattayil, MBBS |
Dr. Kooliyattayil has nothing to disclose. |
| Aiza Siddiqui |
Ms. Siddiqui has nothing to disclose. |
| Mohammad M. Alghaniem, MD |
Dr. Alghaniem has nothing to disclose. |
| Abdelkader Rababah, MD |
Dr. Rababah has nothing to disclose. |
| Fares Qtaishat, MD |
Dr. Qtaishat has nothing to disclose. |
| Dana J. Suboh, MD |
Ms. Suboh has nothing to disclose. |
| Naser Alkasasbeh, MD |
Dr. Alkasasbeh has nothing to disclose. |
| Yumna Aljazi, MD |
Dr. Aljazi has nothing to disclose. |
| raseel i. massad, MD |
Dr. massad has nothing to disclose. |
| Ola Z. Ismail, PhD |
Dr. Ismail has nothing to disclose. |
| Anugraha Sreeram, MBBS |
Dr. Sreeram has nothing to disclose. |
| YERRAGUNTA THIRUMAL, MS MCH |
Dr. THIRUMAL has nothing to disclose. |
| Mohammad S. Mustafa, MD |
Mr. Mustafa has nothing to disclose. |
| Antonia Lefter |
The institution of Miss Lefter has received research support from European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). |
| Ming Jin Lim, MD |
Prof. Lim has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for European Journal of Paediatric Neurology . |
| Laiba Ahsan, MBBS |
Ms. Ahsan has nothing to disclose. |
| Ayesha Ubaid Ullah, MBBS |
Miss Ubaid Ullah has nothing to disclose. |
| Zainab B. Tahir, MBBS |
Dr. Tahir has nothing to disclose. |
| Syeda Shajia Shahid Gillani, MBBS |
Dr. Shahid Gillani has nothing to disclose. |
| Tia L. Chakrapani |
Miss Chakrapani has received personal compensation for serving as an employee of sumaira foundation . |
| Maria D. Alvarez Falcon |
Dr. Alvarez Falcon has nothing to disclose. |
| Berra Nuran Baloglu, Medical Student |
Ms. Baloglu has received personal compensation in the range of $0-$499 for serving as a Medical Transcriptionist (Project-based) with MediTechLabs Türkiye. |
| Mahrosh Iftikhar, MBBS |
Ms. Iftikhar has nothing to disclose. |
| Zsolt L. Illes, MD, PhD |
Prof. Illes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Illes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. |
| Ellen Iacobaeus, MD, PhD |
Dr. Iacobaeus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Iacobaeus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. |
| Maria Hastermann, MD, PhD |
Dr. Hastermann has nothing to disclose. |
| Gregor Brecl Jakob, MD, PhD |
Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Brecl Jakob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. |
| Audrey Lawrence |
Ms. Lawrence has nothing to disclose. |
| Evan Hassan, BS |
Mr. Hassan has nothing to disclose. |
| Presley Limon, Medical Student |
Ms. Limon has nothing to disclose. |
| Ajeet Kumar, Second year medical student |
Mr. Kumar has nothing to disclose. |
| Ushaq Ali, MBBS |
Dr. Ali has nothing to disclose. |
| Muhammad Hassnain, MBBS |
Dr. Hassnain has nothing to disclose. |
| Nadeen Gonna, MD |
Dr. Gonna has nothing to disclose. |
| Ritik Kumar, MBBS |
Dr. Kumar has nothing to disclose. |
| Muhammad A. Khamosh, MBBS |
Mr. Khamosh has nothing to disclose. |
| Simran Nawani, MBBS |
Miss Nawani has nothing to disclose. |
| Dileep Raja R. Kuraku, MD |
Dr. Kuraku has nothing to disclose. |
| Julija Sirina |
Miss Sirina has nothing to disclose. |
| Lena D'Hooghe, PhD |
Dr. D'Hooghe has received personal compensation for serving as an employee of UCB. An immediate family member of Dr. D'Hooghe has received personal compensation for serving as an employee of UCB. An immediate family member of Dr. D'Hooghe has received personal compensation for serving as an employee of Relation Therapeutics. Dr. D'Hooghe has or had stock in UCB. An immediate family member of Dr. D'Hooghe has or had stock in UCB. |
| Suzanne Cole, PhD |
Dr. Cole has nothing to disclose. |
| Elise Hoover, MPH |
Ms. Hoover has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research. |
| Sarah J. Sandison, MSc, MA |
Ms. Sandison has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research . |
| Rocio Lledo |
Dr. Lledo has received personal compensation for serving as an employee of UCB. Dr. Lledo has or had stock in UCB. |
| Kathryn Tsai |
Miss Tsai has nothing to disclose. |
| Navjot Kaur, MBBS |
No disclosure on file
|
| Qamar U. Nisa, Sr., FCPS |
Dr. Nisa has nothing to disclose. |
| Ahsan Tariq, student |
Mr. Tariq has nothing to disclose. |
| Hammad Sarwar |
Mr. Sarwar has nothing to disclose. |
| Nonthikorn Theerasuwipakorn, MD |
Dr. Theerasuwipakorn has nothing to disclose. |
| Wattakorn Laohapiboolrattana, MD |
Mr. Laohapiboolrattana has nothing to disclose. |
| Layla A. Yunes, Student |
Ms. Yunes has nothing to disclose. |
| Nabiha Khan, MBBS |
Dr. Khan has nothing to disclose. |
| Srikar Kintali, MBBS |
Dr. Kintali has nothing to disclose. |
| Laura I. Marte, MD |
Ms. Marte has nothing to disclose. |
| Monserrat López, Other |
Ms. López has nothing to disclose. |
| Meagan King |
Ms. King has nothing to disclose. |
| Raffaella Lombardi, BSc |
Dr. Lombardi has nothing to disclose. |
| Ethan Fechter-Leggett, DVM, MPVM |
Dr. Fechter-Leggett has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research. |
| Mackenzie K. Joe, BA |
Miss Joe has nothing to disclose. |
| FRANCESCA ANDREETTA, PhD |
Dr. ANDREETTA has nothing to disclose. |
| Samanta Mazzetti, PhD |
Dr. Mazzetti has nothing to disclose. |
| Grazia Devigili, MD, PhD |
Dr. Devigili has nothing to disclose. |
| Angelo J. Marino, PA |
Mr. Marino has nothing to disclose. |
| Bhavya Chadalavada, MD |
Dr. Chadalavada has nothing to disclose. |
| Lina K. Zambrano, Md |
Dr. Zambrano has nothing to disclose. |
| Sachin Joshi |
Mr. Joshi has nothing to disclose. |
| Daniele Cartelli, PhD |
Dr. Cartelli has nothing to disclose. |
| Sohan Joshi |
Mr. Joshi has nothing to disclose. |
| Nagarjuna Keshapogu, MD |
Mr. Keshapogu has nothing to disclose. |
| Glory O. Adebajo, MD |
Dr. Adebajo has nothing to disclose. |
| Nicholas Holliday, PhD |
Dr. Holliday has received personal compensation for serving as an employee of Excellerate Bioscience. Dr. Holliday has or had stock in Excellerate Bioscience. |
| Cailey Turner, MD |
Dr. Turner has nothing to disclose. |
| AMALIA CANCIELLO, LT |
Dr. CANCIELLO has nothing to disclose. |
| ANGELA DI MARO |
Dr. DI MARO has nothing to disclose. |
| Anthony A. Donato, Jr., MD |
Dr. Donato has nothing to disclose. |
| Tricha Shivas, MBe |
Mrs. Shivas has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research. Mrs. Shivas has a non-compensated relationship as a consulting/program support with Keenova that is relevant to Â鶹´«Ã½Ó³» interests or activities. Mrs. Shivas has a non-compensated relationship as a consulting/program support with Boehringer Ingelheim that is relevant to Â鶹´«Ã½Ó³» interests or activities. Mrs. Shivas has a non-compensated relationship as a Consulting with Avalyn that is relevant to Â鶹´«Ã½Ó³» interests or activities. Mrs. Shivas has a non-compensated relationship as a Consulting with Insmed that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Mary McGowan, MA |
Ms. McGowan has received personal compensation for serving as an employee of Foundation for Sarcoidosis Research. Ms. McGowan has a non-compensated relationship as a Consulting/Program Support with Keenova (formerly Mallinckrodt Pharmaceuticals) that is relevant to Â鶹´«Ã½Ó³» interests or activities. Ms. McGowan has a non-compensated relationship as a Consulting/Program Support with Boehringer Ingelheim that is relevant to Â鶹´«Ã½Ó³» interests or activities. Ms. McGowan has a non-compensated relationship as a Consulting/Clinical Trial Support with Avalyn that is relevant to Â鶹´«Ã½Ó³» interests or activities. Ms. McGowan has a non-compensated relationship as a Consulting/Program Support with Insmed that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Casey Church |
Miss Church has nothing to disclose. |
| Luis Murguía-Favela, MD |
Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded Therapeutics. Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenxbio. Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioCryst. Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Valeo Pharma. The institution of Dr. Murguía-Favela has received research support from Jeffrey Modell Foundation. An immediate family member of Dr. Murguía-Favela has received personal compensation in the range of $500-$4,999 for serving as a Member of Clinical Panel with Canada Drug's Agency. |
| Leigh Stoddart, PhD |
Dr. Stoddart has nothing to disclose. |
| Simran Arora, MBBS |
Dr. Arora has nothing to disclose. |
| Mar Ribera Armengol, PhD |
Dr. Ribera Armengol has received personal compensation for serving as an employee of UCB. |
| Agney Ranjith Krishnajith |
Mr. Krishnajith has received personal compensation for serving as an employee of ZS Associates. |
| Ashley Huh-Brown, MD |
Dr. Huh-Brown has nothing to disclose. |
| Juan Carlos Moreira Holguín, MD |
Dr. Moreira Holguín has nothing to disclose. |
| Laura A. Singhvi-Hanns |
Laura A. Singhvi-Hanns has received personal compensation for serving as an employee of UCB. |
| Giovanni Signaroldi |
Mr. Signaroldi has nothing to disclose. |
| Kamala Sangam |
Ms. Sangam has received personal compensation for serving as an employee of House of Friendship. An immediate family member of Ms. Sangam has received personal compensation for serving as an employee of House of Friendship. |
| Leslie Serchuck, MD |
Dr. Serchuck has a non-compensated relationship as a BOARD OF DIRECTORS with FOUNDATION FOR SARCOIDOSIS RESEARCH that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Tajdin Jadavji, MD |
Prof. Jadavji has nothing to disclose. |
| Dongxiao Zhang, PhD |
Dr. Zhang has received personal compensation for serving as an employee of Veeva Systems. |
| Fawzi Alnajjar |
No disclosure on file
|
| Nahid Elbaggari |
No disclosure on file
|
| Akira Shishido |
No disclosure on file
|
| Hasmitha Gangireddy |
No disclosure on file
|
| Steven Bieser, MD |
Mr. Bieser has nothing to disclose. |
| Borna Bonakdarpour, MD, FÂ鶹´«Ã½Ó³» |
Dr. Bonakdarpour has nothing to disclose. |
| Elena I. Grebenciucova, MD |
Dr. Grebenciucova has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG therapeutics . Dr. Grebenciucova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Grebenciucova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Grebenciucova has received research support from Lupus Research Alliance . |
| Jason D. Ross, MD |
Dr. Ross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston scientific , Abbott, SPR. Dr. Ross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific . |
| Eric B. Larson, PhD |
Dr. Larson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Holland & Knight. Dr. Larson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gordon, Rees, Scully & Mansukhani. |
| Mohammad Daud Khan, MS |
Mr. Khan has nothing to disclose. |
| Lutfiyya N. Muhammad, PhD |
Dr. Muhammad has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Surgeons. Dr. Muhammad has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis Research & Therapy. |
| Carla M. Cuda, PhD |
Dr. Cuda has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis Research & Therapy. The institution of Dr. Cuda has received research support from NIH NIAID. |
| Kathleen Aren, MPH |
An immediate family member of Mrs. Aren has received personal compensation for serving as an employee of Salvation Army. |
| Asma Qureshi, MPH |
Miss Qureshi has nothing to disclose. |
| Laura Arneson, MD |
Dr. Arneson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werewolf Therapeutics. |
| Deborah Winter, PhD |
Dr. Winter has nothing to disclose. |
| Zachary Orban |
Mr. Orban has nothing to disclose. |
| Yvonne C. Lee, MD |
Dr. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix Pharmaceuticals. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Rheumatology. Dr. Lee has or had stock in GE Healthcare.Dr. Lee has or had stock in CVS Health. The institution of Dr. Lee has received research support from NIH/NIAMS. The institution of Dr. Lee has received research support from Rheumatology Research Foundation. |
| Irene Blanco, MD |
Dr. Blanco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fate Therapeutics. Dr. Blanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blanco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas Biopharma. Dr. Blanco has received research support from Cabaletta. Dr. Blanco has received research support from Novartis. |
| Mary Carns, MS |
Ms. Carns has nothing to disclose. |
| Tyler Therron, MS |
Mr. Therron has nothing to disclose. |
| Thales H. Hein da Rosa, MSc |
Mr. Hein da Rosa has nothing to disclose. |
| Vanessa Manada De Lobos |
Mrs. Manada De Lobos has nothing to disclose. |
| Komel Safdar, MBBS |
Dr. Safdar has nothing to disclose. |
| Anh H. Chung, BS |
Ms. Chung has nothing to disclose. |
| Emily A. Breach |
Ms. Breach has received research support from Rheumatology Research Fund. |
| Rosalind Ramsey-Goldman, MD, DrPH |
Dr. Ramsey-Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Biogen. Dr. Ramsey-Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adicet. Dr. Ramsey-Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autolus. Dr. Ramsey-Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Lupus Therapeutics. Dr. Ramsey-Goldman has received research support from NIH-to Northwestern University for my effort on the grant. Dr. Ramsey-Goldman has received research support from NIH-paid to Northwestern University for my effort ont he grant. Dr. Ramsey-Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a consultant on grants with American College of Rheumatology-paid to Northwestern University for effort on grant. Dr. Ramsey-Goldman has received personal compensation in the range of $0-$499 for serving as a grant reviewer with Lupus Foundation of American. |
| Jing Song |
Mrs. Song has nothing to disclose. |
| John Seagrist |
Mr. Seagrist has nothing to disclose. |
| Cecilia Stumpf |
Ms. Stumpf has or had stock in Gilead Sciences.Ms. Stumpf has or had stock in Novo nordisk. |
| Mary Mahieu, MD |
Dr. Mahieu has or had stock in Abbvie.Dr. Mahieu has or had stock in Abbott Laboratories.Dr. Mahieu has or had stock in Baxter International.Dr. Mahieu has or had stock in Johnson & Johnson.Dr. Mahieu has or had stock in Kimberly Clark.Dr. Mahieu has or had stock in Pfizer.Dr. Mahieu has or had stock in Takeda Pharmaceutical. |
| Harris Perlman, PhD |
Dr. Perlman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis Research and Therapy. |
| Katherine R. Puev |
Ms. Puev has nothing to disclose. |
| Mariam Siddiqui, MD |
Ms. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Ms. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. |
| Neil Pillai, MS |
Mr. Pillai has nothing to disclose. |
| Ning Zhong, MD |
Dr. Zhong has nothing to disclose. |
| Mark Waheed, DO |
Dr. Waheed has nothing to disclose. |
| Elias S. Sotirchos, MD |
Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health. |
| Ahmed Z. Obeidat, MD, PhD |
Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Veronica A. Tkachuk |
Veronica A. Tkachuk has nothing to disclose. |
| Sami Fam |
Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca. |
| Jin Nakahara, MD, PhD, FÂ鶹´«Ã½Ó³» |
Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Japan Society for the Promotion of Science. |
| Lindsey Przybyl |
Lindsey Przybyl has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Lindsey Przybyl has stock in AstraZeneca. |
| Cynthia Carrillo Infante, MD, PhD |
No disclosure on file
|
| Lokesh Jha, MD |
Dr. Jha has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Jha has or had stock in Alexion Pharmaceuticals. |
| Feifei Yang |
Feifei Yang has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Feifei Yang has stock in Alexion Pharmaceuticals. |
| Ukwen Akpoji, PharmD |
Dr. Akpoji has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Akpoji has received personal compensation for serving as an employee of Pfizer, Inc. Dr. Akpoji has stock in Alexion, AstraZeneca Rare Disease. |
| Samirah Qureshi, MD |
Dr. Qureshi has nothing to disclose. |
| Katie Gonsalves, RN |
Ms. Gonsalves has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Ms. Gonsalves has or had stock in AstraZeneca . |
| Meghana Koneru, PhD |
Dr. Koneru has nothing to disclose. |
| Karissa Gable, MD, FÂ鶹´«Ã½Ó³» |
Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accordant. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazenca. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols . Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for annexon. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. |
| Chafic Y. Karam, MD |
Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. |
| Jeffrey A. Allen, MD |
Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson. |
| Charalampia Koutsioumpa, MD, PhD |
Dr. Koutsioumpa has nothing to disclose. |
| Nizar Chahin, MD |
Dr. Chahin has nothing to disclose. |
| Srikanth Muppidi, MD, FÂ鶹´«Ã½Ó³» |
Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care. |
| Reza Seyedsadjadi, MD |
Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation. |
| Mazen M. Dimachkie, MD, FÂ鶹´«Ã½Ó³» |
Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Â鶹´«Ã½Ó³» (Â鶹´«Ã½Ó³»). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (Â鶹´«Ã½Ó³»EM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. |
| Bhaskar Roy, MD, FÂ鶹´«Ã½Ó³» |
Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx. |
| Long F. Davalos, MD |
Dr. Davalos has nothing to disclose. |
| Waleed Khan, MD |
Dr. Khan has nothing to disclose. |
| Alexander H. Morrison, MD |
Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Candid Therapeutics. Dr. Morrison has received research support from Dianthus Therapeutics. |
| Mia Weisman |
Ms. Weisman has nothing to disclose. |
| Alexander Diefes, BS |
Mr. Diefes has nothing to disclose. |
| Anastasia Zekeridou, MD, PhD, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Andrew McKeon, MD |
The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Divyanshu Dubey, MD, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Jeffrey W. Britton, MD, FÂ鶹´«Ã½Ó³» |
Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society. |
| Laura Cacciaguerra, MD, PhD |
Dr. Cacciaguerra has nothing to disclose. |
| Kelsey M. Smith, MD |
The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals. |
| Anuja R. Patil, MD, DM |
Dr. Patil has nothing to disclose. |
| Binxia Yang |
Binxia Yang has nothing to disclose. |
| Andreu Vilaseca-Jolonch, MD |
Dr. Vilaseca-Jolonch has received research support from Fundación Martín Escudero. |
| Andrea Stabile, MD |
Dr. Stabile has nothing to disclose. |
| Kerly Guevara Maldonado, MD |
Dr. Guevara Maldonado has nothing to disclose. |
| Suvyaktha Simha |
Ms. Simha has nothing to disclose. |
| Michael Basso, PhD |
Dr. Basso has nothing to disclose. |
| P. James B. Dyck, MD, FÂ鶹´«Ã½Ó³» |
Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis. |
| Marcus Vinicius R. Pinto, MD |
Dr. Pinto has nothing to disclose. |
| Naveen K. Paramasivan, MD |
Dr. Paramasivan has nothing to disclose. |
| Christopher J. Klein, MD, FÂ鶹´«Ã½Ó³» |
Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. |
| Michelle L. Mauermann, MD, FÂ鶹´«Ã½Ó³» |
The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care. |
| Nathan P. Staff, MD, PhD, FÂ鶹´«Ã½Ó³» |
Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health. |
| Nathan P. Young, DO |
Dr. Young has nothing to disclose. |
| E. M. Hoffman, DO, PhD |
Dr. Hoffman has nothing to disclose. |
| Catarina Aragon Pinto, MD |
Dr. Aragon Pinto has nothing to disclose. |
| Felipe Jones, MD |
Dr. Jones has nothing to disclose. |
| Cherine N. Fawaz, MD |
Dr. Fawaz has nothing to disclose. |
| Haidara Kherbek, MD |
Haidara Kherbek has nothing to disclose. |
| Scott D. Newsome, DO, FÂ鶹´«Ã½Ó³» |
Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche. |
| Carlos A. Pardo-Villamizar, MD |
The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| David Acero-Garces, MD |
Dr. Acero-Garces has nothing to disclose. |
| Clare M. Lambert, MD |
Dr. Lambert has nothing to disclose. |
| Daniela Riveros Acosta, MD |
Dr. Riveros Acosta has nothing to disclose. |
| Asli Buyukkurt, MD |
Dr. Buyukkurt has nothing to disclose. |
| andrea cepeda, MD |
Dr. cepeda has nothing to disclose. |
| Patricia I. Redondo, Undergraduate |
Miss Redondo has nothing to disclose. |
| Dylan Kirschenbaum, MD |
Dr. Kirschenbaum has nothing to disclose. |
| Johanna L. Rosenthal, MD |
Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Rosenthal with California Neurology Society. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Board of Directors Legislative Chairman4 with California Neurology Society. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Board of Directors, Legislative Chair202 with California Neurology Society. |
| Jessica Benson |
Miss Benson has nothing to disclose. |
| Adnan Ismail |
Mr. Ismail has nothing to disclose. |
| Rishika Cherukuru |
Ms. Cherukuru has nothing to disclose. |
| Paul Brindley |
Paul Brindley has nothing to disclose. |
| Ashley Brizendine-Wijayawardana |
Ashley Brizendine-Wijayawardana has nothing to disclose. |
| Sandia Lohana, MBBS |
Dr. Lohana has nothing to disclose. |
| Arooba Iqbal |
Dr. Iqbal has nothing to disclose. |
| Aresha Kumari |
Aresha Kumari has nothing to disclose. |
| Bhawna Kumari |
No disclosure on file
|